The National Dairy Development Board (NDDB) set up Indian Immunologicals Ltd. (IIL) in 1982 with the objective of making Foot and Mouth Disease (FMD) vaccine available to farmers at an affordable price. The technology for FMD vaccine manufacture was obtained from M/s. Wellcome Foundation Limited, United Kingdom. The plant in Hyderabad today has a capacity to make 80 million trivalent doses of FMD vaccine. Following the successful introduction of Foot &Mouth Disease Vaccine-Raksha, IIL launched the tissue culture vaccine "Raksharab" in 1989. This was the first Indian tissue culture vaccine in the market. Subsequently IIL has developed many biologicals through its own R&D efforts and launched several vaccines in the Indian market at affordable prices. IIL is today the fifth largest animal health player in the Indian market and the market leader in veterinary biologicals in India. It operates one of the largest plants in the world for veterinary vaccines and is WHO-GMP and ISO-9001 certified. IIL exports its products to several countries and exports contributed substantially to the company's turnover.

IIL pursues not only the mandate of NDDB to provide products and services to enhance the quality of livestock in the country but also use its technological capabilities to the benefit of the people of India. IIL strongly believes that its mission of "Biotechnology in healthcare made affordable and accessible" can be actively pursued only with a sound technology base in modern biotechnology. IIL operates a facility in Ooty to manufacture the Vero cell culture rabies vaccine for use in human beings. This plant was set up in 1998 at the specific request of the Government of India so that the country can phase out use of the older and unsafe sheep brain vaccine (also termed nerve tissue vaccine – NTV) with the modern tissue culture vaccine. IIL sells the product under the brand name "Abhayrab" through its network of "Abhayclinics".

IIL is the second company in the world to launch the purified Vero cell rabies vaccine (PVRV). The vaccine is sold at very economical price when compared to the brands of multinational companies. A new vaccine facility in Hyderabad has been setup to manufacture various other human vaccines such as Diphtheria, Pertussis, Tetanus, Recombinant Hepatitis B, Hepatitis A and Measles.

Achievements:

1983: Foot and Mouth Disease vaccine plant commissioned.
1985: Animal health products for the cooperative sector Introduced.
1989:

• First Indian company to manufacture tissue culture Veterinary Rabies vaccine.
• Tropical Theileriosis vaccine for cattle, first of its kind in the world.

1992:

• Introduction of Haemorrhagic Septicaemia (HS) and Black Quarter (BQ) Vaccines
• Introduction of Xylazine Hydrochloride injection, based on in-house research.

1996: Introduction of Enterotoxaemia vaccine.
1997: Awarded WHO GMP certification. Export avenues opened.
1998:

• Awarded ISO 9002 Certification.
• FMD – Ovac ((FMD adjuvant vaccine) introduced
• Vaccines for sheep and canines introduced.
• Human Rabies vaccine plant at Ooty commissioned.

1999:

• 'Abhayrab' introduced; Veterinary formulations range expanded.
• Abhay Clinics for mission of 'Immunity made Affordable'.

2000: World ’s first combination vaccine for FMD, HS and BQ – Raksha Triovac.
2001:

• Unique medicated feed pellets – Vetfen-600 launched.
• Emerges as India ’s largest veterinary product exporter.

2002:

• Vaccine for Brucellosis in cattle launched.
• Human vaccine portfolio increased with Measles and MMR vaccine.
• Launched 'Operation Pratirodh' – Animal Health vaccination services.

2003:

• New Human Vaccines plant and Research and Development Center inaugurated.
• Introduction of unique concept of Fenbendazole through feed pellate.

2004:

• Nimovet-world’s first Nimesulide injection for livestock introduced.
• Indiagen Ltd, a company offering scientific &professional breeding services launched.
• IIL emerges as the fifth largest animal health company in India.
• Raksha FMD Vaccine emerges as the largest animal health brand in India.

2005: Abhayrig, an affordable immunoglobulin to treat class 3 dog bites introduced.
2006:

• Launch of the first vaccine from the Human Vaccine Manufacturing Plant Hyderabad – Elovac-B (r-DNA Hepatitis-B vaccine).
• 4th largest company in domestic animal health market
• Achieved milestone of Rs.100 Crores sales turnover
• Indian Immunologicals Ltd. wins the first 'Corporate social responsibility' award instituted by Animal Pharm

2007

• Launch of indigenously produced Measles Vaccine
• Launch of Raksha-PPR (Pestis des petits Ruminants) vaccine
• Launch of Animal Nutrition Division – Calsagar, Goumix, Goumin.
• IIL’s sales turnover reached Rs.158 Crores in 2006-07.

Corporate Office:

Indian Immunologicals Ltd.
Road # 44,
Jubilee Hills,
Hyderabad – 500 033
India.

Tel: +91-40-23544585/+91-40-23544593/+91-9948298322/+91-9948298422
Fax: +91-40-23544007

List of Offices

http://www.indimmune.com

Read original blog post